Home Articles

Articles

Articles

She’s 31, Has Stage 4 Kidney Cancer — And Talked Openly About It in a Job Interview

Bruce Horovtiz - June 6, 2022

Survey Finds Oncologists Have Grown More Comfortable With CAR-T Therapy

Child patient with IV line in hand sleep on hospital bed

A more Targeted Approach in Pediatric Cancer Therapy?

Humanizing Healthcare: A Conversation with Summer Knight, MD, MBA

The History, Reality and Promise of Immunotherapy for Cancer

An Evolution to Genomic Testing for DCIS

Leonard A. Farber, MD - February 5, 2021

More Cancer Deaths due to COVID-19-related Delay in Cancer Screening and...

Danielle Garcia - December 22, 2020

Social Needs Linked to Low Health-Related Quality of Life Among African...

Editorial Team - November 23, 2020

Improving the Identification of Therapeutic Vulnerabilities in Breast Cancer

Editorial Team - November 18, 2020

Combinability: Addressing Unmet Need in AML

David A. Roth, M.D. - August 20, 2020

Blood test

Detect Cancer Early: Liquid Biopsy Based ctDNA Methylation as a Promising...

Dhruvajyoti Roy, Ph.D. - March 20, 2020

Smoking Cessation as an Integral Part of the Treatment of Patients...

Peter Hofland, Ph.D - February 24, 2020

Featured Image: ELECT-particles on RBCs. This scanning electron microscope (SEM) image shows drug-loaded nanoparticles bound to mouse erythrocytes (red blood cells). Photo Courtesy: Wyss Institute at Harvard University

Drug-loaded Nanoparticles Bound to Circulating Red Blood Cells Inhibit Lung Cancer...

Lindsay Brownell - November 14, 2019

Render of t-cells. Courtesy 2019 Fotolia.

Broadening the Applicability of CAR-T Immunotherapy to Treat the Untreatable

Filippo Petti - October 24, 2019

Nobel Prize in Physiology or Medicine 2019: How do Cells Sense...

Peter Hofland, Ph.D - October 10, 2019

12 3 4 Page 1 of 4

LATEST NEWS

Study: Blocking Immune Suppressor Cells in Mice with Glioblastoma Improves Survival

Danielle Garcia - January 27, 2023

Stephen Spellman: Mismatched Unrelated Donors – Key to Erasing the Gap in Donor Availability...

Editorial Team - January 18, 2023

New Technologies in Post-surgical Wound Dressings

Brad Greer, JD - January 16, 2023

The Patient Journey Tech Stack: 10 Predictions for 2023

Yishai Knobel - January 16, 2023

Study Confirms: ‘Extreme Lack of Consistency’ Hampers the Potential of Nanosized Medicines

Danielle Garcia - January 12, 2023

Press Releases | Cancer

Java Original Coffee Company to Support The Onco’Zine Brief Radio... January 25, 2023
The Java Original Coffee Company, the home of incredible artisan roasted gourmet coffee, is committed to support the cancer research community as well as select individuals and organizations involved...(PRWeb January 25, 2023)Read the full story at https://www.prweb.com/releases/java_original_coffee_company_to_support_the_oncozine_brief_radio_broadcast_and_podcast/prweb19133000.htm
GO2 for Lung Cancer Addresses Disparities and Health Inequities... January 23, 2023
Through efforts in awareness, education and readily available resources, GO2 for Lung Cancer is helping underserved communities access information and education needed to increase survival rates.(PRWeb January 23, 2023)Read the full story at https://www.prweb.com/releases/go2_for_lung_cancer_addresses_disparities_and_health_inequities_head_on_in_underserved_communities/prweb19126525.htm
$1.3 Billion Liquid Biopsy Market the Present and Future of Clinical... January 20, 2023
Dramatic changes have occurred in the global liquid biopsy market that continue to impact how medical professionals diagnosis, treat, and monitor cancer.(PRWeb January 20, 2023)Read the full story at https://www.prweb.com/releases/1_3_billion_liquid_biopsy_market_the_present_and_future_of_clinical_oncology/prweb19123773.htm